Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ascendis
Pharma
Ascendis must wait 3 more months for FDA verdict on TransCon PTH
It’s been a long wait for Ascendis to score FDA approval for its hormone replacement therapy TransCon PTH. Now, it’ll take another three months.
Kevin Dunleavy
May 14, 2024 5:36pm
AstraZeneca, BeiGene, Coherus—Fierce Pharma Asia
Dec 1, 2023 8:34am
Pfizer gets EU approval for long-acting human growth hormone
Feb 22, 2022 7:30am
The potential blockbusters still awaiting FDA decisions in 2021
Sep 13, 2021 10:57am
Ascendis' long-acting growth hormone wins FDA blessing
Aug 25, 2021 7:33pm
Ascendis files IND for sustained-release, anti-cancer TLR drug
Jan 5, 2021 7:35am
